Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Miller

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Nature Neuroscience|February 4, 2022
Disentangling glial diversity in peripheral nerves at single-nuclei resolutionAldrin K Y Yim, Peter L Wang, John R Bermingham, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2021
Acute <i>Trem2</i> reduction triggers increased microglial phagocytosis, slowing amyloid deposition in miceKathleen M Schoch, Lubov A Ezerskiy, Michaela M Morhaus, et al.
Muscle & Nerve|April 23, 2015
Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosisSabrina Paganoni, Theodore Hyman, Amy Shui, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 27, 2010
Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutationGlenn Lopate, Robert H Baloh, Muhammad T Al-Lozi, et al.
European Journal of Pharmacology|December 12, 2017
Synthesis and in vitro characterization of a P2X7 radioligand [<sup>123</sup>I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer diseaseHongjun Jin, Junbin Han, Derek Resing, et al.
JAMA Neurology|November 14, 2012
SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapyLeah Winer, Dushyanth Srinivasan, Seung Chun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisSoumya Mukherjee, Rama Koppisetti, Nicolas R Barthélemy, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Protein production is an early biomarker for RNA-targeted therapiesWade K Self, Kathleen M Schoch, Jacob Alex, et al.
Neuron|May 24, 2016
Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse ModelKathleen M Schoch, Sarah L DeVos, Rebecca L Miller, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Nature Neuroscience|February 4, 2022
Disentangling glial diversity in peripheral nerves at single-nuclei resolutionAldrin K Y Yim, Peter L Wang, John R Bermingham, et al.
JCI Insight|December 7, 2021
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunctionLubov A Ezerskiy, Kathleen M Schoch, Chihiro Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2021
Acute <i>Trem2</i> reduction triggers increased microglial phagocytosis, slowing amyloid deposition in miceKathleen M Schoch, Lubov A Ezerskiy, Michaela M Morhaus, et al.
Muscle & Nerve|April 23, 2015
Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosisSabrina Paganoni, Theodore Hyman, Amy Shui, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 27, 2010
Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutationGlenn Lopate, Robert H Baloh, Muhammad T Al-Lozi, et al.
European Journal of Pharmacology|December 12, 2017
Synthesis and in vitro characterization of a P2X7 radioligand [<sup>123</sup>I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer diseaseHongjun Jin, Junbin Han, Derek Resing, et al.
JAMA Neurology|November 14, 2012
SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapyLeah Winer, Dushyanth Srinivasan, Seung Chun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisSoumya Mukherjee, Rama Koppisetti, Nicolas R Barthélemy, et al.
Annals of Clinical and Translational Neurology|December 20, 2018
Protein production is an early biomarker for RNA-targeted therapiesWade K Self, Kathleen M Schoch, Jacob Alex, et al.
Neuron|May 24, 2016
Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse ModelKathleen M Schoch, Sarah L DeVos, Rebecca L Miller, et al.
Pageof 13